Literature DB >> 19050709

Concurrent urinary tract infection and stone disease: pathogenesis, diagnosis and management.

Ben Thomas1, David Tolley.   

Abstract

Urinary tract stones and urinary tract infection are strongly associated. Infection is implicated as the cause of stones in about 15% of stone formers, and the development of infection can complicate the management of pre-existing stones. Left untreated, both situations can result in loss of kidney function, and can, on occasion, be life threatening. The underlying pathophysiology of infection stones is generally well understood, but factors dictating why a particular individual should be affected are less clear, although obstruction is a uniformly recognized risk factor. Surgery is the mainstay of treatment for infection calculi: stone clearance is the goal and a range of minimally invasive treatments is available. Systemic sepsis remains the most serious complication of treatment, and, although rare, still occurs despite antibiotic prophylaxis. Once the stone and the causative infection have been removed, various strategies can be employed to minimize the risk of recurrence. When infection complicates pre-existing stone disease, the primary aim of management is to treat the infective episode and delay definitive stone management until the infection has cleared. In such cases where obstruction is also present, prompt drainage of the affected kidney is likely to prevent permanent renal damage, and may be life saving.

Entities:  

Mesh:

Year:  2008        PMID: 19050709     DOI: 10.1038/ncpuro1254

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  12 in total

1.  High carbonate level of apatite in kidney stones implies infection, but is it predictive?

Authors:  Kate M Englert; James A McAteer; James E Lingeman; James C Williams
Journal:  Urolithiasis       Date:  2013-07-24       Impact factor: 3.436

2.  Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence.

Authors:  S Proietti; A Giannantoni; L G Luciani; G Sortino; P Graziotti; G Giusti
Journal:  Urolithiasis       Date:  2014-06-28       Impact factor: 3.436

3.  Bladder stones in vesicovaginal fistula: is concurrent repair an option? Experience with 87 patients.

Authors:  Steven N Shephard; Sunday J Lengmang; Carolyn V Kirschner
Journal:  Int Urogynecol J       Date:  2016-09-17       Impact factor: 2.894

4.  Approach to the Adult Kidney Stone Former.

Authors:  Naim Maalouf
Journal:  Clin Rev Bone Miner Metab       Date:  2012-03

5.  Hanging Bladder calculi Secondary to Misplaced Surgical Suture.

Authors:  Ali Mahdavi; Hasan Mostafavi
Journal:  Iran J Radiol       Date:  2015-04-15       Impact factor: 0.212

6.  A Novel Urease Inhibitor of Ruminal Microbiota Screened through Molecular Docking.

Authors:  Zhenyu Zhang; Ming Li; Xiaoyin Zhang; Nan Zheng; Shengguo Zhao; Jiaqi Wang
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

7.  The SCQ-SCORE: initial validation of a new scoring system for elective stone surgery prioritization in the COVID-19 era.

Authors:  Daniel Pérez Fentes; Carlos Fernández Baltar; Juan Núñez Otero; Rita Diz Gil; Francisco Gude Sampedro
Journal:  Cent European J Urol       Date:  2021-03-11

8.  A case-control study on the association between bladder cancer and prior bladder calculus.

Authors:  Shiu-Dong Chung; Ming-Chieh Tsai; Ching-Chun Lin; Herng-Ching Lin
Journal:  BMC Cancer       Date:  2013-03-15       Impact factor: 4.430

9.  Association of staphylococcus cohnii subspecies urealyticum infection with recurrence of renal staghorn stone.

Authors:  Zahra Shahandeh; Hamid Shafi; Farahnaz Sadighian
Journal:  Caspian J Intern Med       Date:  2015

10.  Vitamin C inhibits crystallization of struvite from artificial urine in the presence of Pseudomonas aeruginosa.

Authors:  Muhammed A P Manzoor; Surya Ram Duwal; M Mujeeburahiman; Punchappady-Devasya Rekha
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.